Medline Inc.

MDLN Healthcare Medical Instruments & Supplies

Medline Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.4 billion, up 11.5% from fiscal 2024.

Revenue
+14.1%
Free cash flow
+916.1%
Total debt
−23.7%

Quarter to September 2026, against a year earlier

39.96 0.39 −0.97%
Market cap
$52.3B
P/E
58.4×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
2.25
Beneish M
−2.38
Dividend safety
n/a

Medline Inc. (MDLN) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Medline Inc. (MDLN) trades at a EV/Sales of 1.5×. Over the past ten years it has ranged from 0.0× (March 2026) to 1.7× (April 2026); the current reading is higher than 77% of that period. That is below the Medical Instruments & Supplies industry median of 2.8× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —

Quarterly newest first

Period EV/Sales Change
Sep 2026 1.3× (10.66%)
Jun 2026 1.5× (9.86%)
Mar 2026 1.6× —
Dec 2025 0.0× —
2 more quarters

Against its own ten years

Low 0.0× High 1.7×
Ten-year median 1.3×
Current reading's percentile 77

EV/Sales against peers

Company EV/Sales
MDLN Medline Inc. 1.5×
BAX Baxter International Inc. compare 1.7×
SOLV Solventum Corporation compare 2.4×
BDX Becton, Dickinson and Company compare 3.4×
COO The Cooper Companies, Inc. compare 3.5×
ALC Alcon compare 3.7×
RMD ResMed Inc. compare 5.8×
WST West Pharmaceutical Services, Inc. compare 8.1×
ISRG Intuitive Surgical, Inc. compare 13.7×
Medical Instruments & Supplies industry median 2.8×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on MDLN